|
1
|
Cho NH, Shaw JE, Karuranga S, Huang Y, da
Rocha Fernandes JD, Ohlrogge AW and Malanda B: IDF diabetes atlas:
Global estimates of diabetes prevalence for 2017 and projections
for 2045. Diabetes Res Clin Pract. 138:271–281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheung N, Mitchell P and Wong TY: Diabetic
retinopathy. Lancet. 376:124–136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Flaxman SR, Bourne R, Resnikoff S, Ackland
P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen
JH, et al: Global causes of blindness and distance vision
impairment 1990-2020: A systematic review and meta-analysis. Lancet
Glob Health. 5:e1221–e1234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ting DS, Cheung GC and Wong TY: Diabetic
retinopathy: Global prevalence, major risk factors, screening
practices and public health challenges: A review. Clin Exp
Ophthalmol. 44:260–277. 2016. View Article : Google Scholar
|
|
5
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giannella A, Radu CM, Franco L, Campello
E, Simioni P, Avogaro A, de Kreutzenberg SV and Ceolotto G:
Circulating levels and characterization of microparticles in
patients with different degrees of glucose tolerance. Cardiovasc
Diabetol. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hulsmans M and Holvoet P:
MicroRNA-containing microvesicles regulating inflammation in
association with atherosclerotic disease. Cardiovasc Res. 100:7–18.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pishavar E and Behravan J: miR-126 as a
therapeutic agent for diabetes mellitus. Curr Pharm Design.
23:3309–3314. 2017. View Article : Google Scholar
|
|
9
|
Qin LL, An MX, Liu YL, Xu HC and Lu ZQ:
MicroRNA-126: A promising novel biomarker in peripheral blood for
diabetic retinopathy. Int J Ophthalmol. 10:530–534. 2017.PubMed/NCBI
|
|
10
|
Bao J, Yu Y, Chen J, He Y, Chen X, Ren Z,
Xue C, Liu L, Hu Q, Li J, et al: MiR-126 negatively regulates PLK-4
to impact the development of hepatocellular carcinoma via ATR/CHEK1
pathway. Cell Death Dis. 9:10452018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maniswami RR, Prashanth S, Karanth AV,
Koushik S, Govindaraj H, Mullangi R, Rajagopal S and Jegatheesan
SK: PLK4: A link between centriole biogenesis and cancer. Expert
Opin Ther Targets. 22:59–73. 2018. View Article : Google Scholar
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
13
|
Chou JC, Rollins SD and Fawzi AA: Trypsin
digest protocol to analyze the retinal vasculature of a mouse
model. J Vis Exp. 76:e504892013.
|
|
14
|
Semkova I, Huemmeke M, Ho MS, Merkl B,
Abari E, Paulsson M, Joussen AM and Plomann M: Retinal localization
of the glutamate receptor GluR2 and GluR2-regulating proteins in
diabetic rats. Exp Eye Res. 90:244–253. 2010. View Article : Google Scholar
|
|
15
|
Zhuang P, Muraleedharan CK and Xu S:
Intraocular delivery of miR-146 inhibits diabetes-induced retinal
functional defects in diabetic rat model. Invest Ophthalmol Vis
Sci. 58:1646–1655. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu WL: MicroRNA-9 inhibits retinal
neovascularization in rats with diabetic retinopathy by targeting
vascular endothelial growth factor A. J Cell Biochem.
120:8032–8043. 2018. View Article : Google Scholar
|
|
17
|
Zampetaki A, Kiechl S, Drozdov I, Willeit
P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E,
et al: Plasma microRNA profiling reveals loss of endothelial
miR-126 and other microRNAs in type 2 diabetes. Circ Res.
107:359–810. 2010. View Article : Google Scholar
|
|
18
|
Meister J and Schmidt MHH: miR-126 and
miR-126*: New players in cancer. ScientificWorldJournal.
10:2090–2100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trost A, Lange S, Schroedl F, Bruckner D,
Motloch KA, Bogner B, Kaser-Eichberger A, Strohmaier C, Runge C,
Aigner L, et al: Brain and retinal pericytes: Origin, function and
role. Front Cell Neurosci. 10:202016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song E, Dong Y, Han LN, Sui D, Xu Q, Wang
X and Wu J: Diabetic retinopathy: VEGF, bFGF and retinal vascular
pathology. Chinese Med J (Engl). 117:247–251. 2004.
|
|
21
|
Ekerbicer N, Gurpinar T, Sisman AR,
Guvendi G, Camsari UM and Uysal N: Statins reduce testicular and
ocular VEGF: A potential compromise to microcirculation. Microvasc
Res. 119:60–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simó R and Hernández C; European
Consortium for the Early Treatment of Diabetic Retinopathy
(EUROCONDOR): Neurodegeneration in the diabetic eye: New insights
and therapeutic perspectives. Trends Endocrinol Metab. 25:23–33.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karthikkeyan G, Nareshkumar RN, Aberami S,
Sulochana KN, Vedantham S and Coral K: Hyperglycemia induced early
growth response-1 regulates vascular dysfunction in human retinal
endothelial cells. Microvasc Res. 117:37–43. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao J, Wang J, Yao Y, Wang K, Zhou Q and
Tang Y: miR-133b regulates proliferation and apoptosis in
high-glucose-induced human retinal endothelial cells by targeting
ras homolog family member A. Int J Mol Med. 42:839–850.
2018.PubMed/NCBI
|
|
25
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hua Y, Liang C, Miao C, Wang S, Su S, Shao
P, Liu B, Bao M, Zhu J, Xu A, et al: MicroRNA-126 inhibits
proliferation and metastasis in prostate cancer via regulation of
ADAM9. Oncol Lett. 15:9051–9060. 2018.PubMed/NCBI
|
|
27
|
Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N,
Zhou X and Chen C: Reduced miR-126 expression facilitates
angiogenesis of gastric cancer through its regulation on VEGF-A.
Oncotarget. 5:11873–11885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen M, Peng W, Hu S and Deng J:
miR-126/VCAM-1 regulation by naringin suppresses cell growth of
human non-small cell lung cancer. Oncol Lett. 16:4754–4760.
2018.PubMed/NCBI
|
|
29
|
Ebrahimi F, Gopalan V, Smith RA and Lam
AK: miR-126 in human cancers: Clinical roles and current
perspectives. Exp Mol Pathol. 96:98–107. 2014. View Article : Google Scholar
|
|
30
|
Zhai X and Xu W: Long noncoding RNA ATB
promotes proliferation, migration, and invasion in bladder cancer
by suppressing microRNA-126. Oncol Res. 26:1063–1072. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Press MF, Xie B, Davenport S, Zhou Y,
Guzman R, Nolan GP, O'Brien N, Palazzolo M, Mak TW, Brugge JS and
Slamon DJ: Role for polo-like kinase 4 in mediation of cytokinesis.
Proc Natl Acad Sci USA. 116:11309–11318. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Veitch ZW, Cescon DW, Denny T, Yonemoto
LM, Fletcher G, Brokx R, Sampson P, Li SW, Pugh TJ, Bruce J, et al:
Safety and tolerability of CFI-400945, a first-in-class, selective
PLK4 inhibitor in advanced solid tumours: A phase 1 dose-escalation
trial. Br J Cancer. 121:318–324. 2019. View Article : Google Scholar : PubMed/NCBI
|
